Balancing Customer Variety and Standardization
Every variant you add for a customer brings hidden costs. The real winners offer meaningful choice with minimal internal complexity — here is how.
Zombie variants are product options that remain active in the catalog but generate little or no sales, silently consuming engineering, procurement, and service resources.
Zombie variants are product configurations or options that remain active in the product catalog but are rarely or never ordered in practice. Like their namesake from folklore, they refuse to disappear — yet they consume resources without delivering value. In variant management, zombie variants are a direct consequence of inadequate portfolio governance.
Zombie variants rarely appear all at once. They build up gradually when new variant requests are approved without a clear threshold for minimum viability, and when the portfolio is never systematically reviewed.
Common entry points include:
The defining characteristic of zombie variants is the gap between their catalog status and their actual demand. But catalog status is not free. Each active variant — no matter how infrequently ordered — typically requires:
A single zombie variant may seem harmless. A portfolio of dozens or hundreds is a measurable overhead — one that accumulates invisibly unless someone specifically tracks variant-level sales and costs.
The most direct method is variant-level sales analysis: for each active option or configuration, how often has it been ordered in the last two to three years? Options with zero or near-zero demand relative to their maintenance cost are candidates for retirement.
Beyond frequency, consider:
Eliminating zombie variants requires both an analytical decision and an organizational process to act on it. Effective approaches include:
Not every low-volume variant is a zombie. A variant may sell rarely but still be strategically justified — for a key account, a regulated market, or as a platform component shared across the portfolio. A zombie variant is one where even this justification is absent: no strategic rationale, no meaningful demand, yet still consuming catalog and maintenance resources.
Most companies that actively manage variant portfolios conduct formal reviews annually, aligned with product roadmap or pricing cycles. Companies with fast-moving portfolios or high variant counts may review more frequently. The key is that reviews happen on a fixed schedule and are backed by actual sales data — not driven by gut feeling or customer pressure alone.